| 000 | 01920 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250517063848.0 | ||
| 264 | 0 | _c20160504 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1520-4804 | ||
| 024 | 7 |
_a10.1021/acs.jmedchem.5b01482 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSosič, Izidor | |
| 245 | 0 | 0 |
_aStructure-Activity Relationships of Novel Tryptamine-Based Inhibitors of Bacterial Transglycosylase. _h[electronic resource] |
| 260 |
_bJournal of medicinal chemistry _cDec 2015 |
||
| 300 |
_a9712-21 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAnti-Bacterial Agents _xchemistry |
| 650 | 0 | 4 |
_aEnterococcus faecium _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
| 650 | 0 | 4 |
_aEscherichia coli Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMethicillin Resistance |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aPenicillin-Binding Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aPeptidoglycan Glycosyltransferase _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProtein Binding |
| 650 | 0 | 4 |
_aSerine-Type D-Ala-D-Ala Carboxypeptidase _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
| 650 | 0 | 4 | _aStructure-Activity Relationship |
| 650 | 0 | 4 |
_aTryptamines _xchemistry |
| 650 | 0 | 4 |
_aUridine Diphosphate N-Acetylmuramic Acid _xanalogs & derivatives |
| 700 | 1 | _aAnderluh, Marko | |
| 700 | 1 | _aSova, Matej | |
| 700 | 1 | _aGobec, Martina | |
| 700 | 1 | _aMlinarič Raščan, Irena | |
| 700 | 1 | _aDerouaux, Adeline | |
| 700 | 1 | _aAmoroso, Ana | |
| 700 | 1 | _aTerrak, Mohammed | |
| 700 | 1 | _aBreukink, Eefjan | |
| 700 | 1 | _aGobec, Stanislav | |
| 773 | 0 |
_tJournal of medicinal chemistry _gvol. 58 _gno. 24 _gp. 9712-21 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/acs.jmedchem.5b01482 _zAvailable from publisher's website |
| 999 |
_c25467334 _d25467334 |
||